Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma

Annals of Allergy, Asthma and Immunology

Volumn 88, Issue 2, 2002, Pages 227-235

  Pearlman, David S ^a   White, Martha V ^b   Lieberman, Allen K ^c   Pepsin, Pamela J ^d   Kalberg, Chris ^d   Emmett, Amanda ^d   Bowers, Brian ^d   Rickard, Kathleen A ^d   Dorinsky, Paul ^d  

^a Respiratory Institute   (United States)

^b Institute for Asthma and Allergy   (United States)

^c HealthQuest Therapy/Res Inst Inc   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; SALBUTAMOL; SALMETEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SYMPTOM;

EID: 0036176066     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62001-7     Document Type: Article

References (30)

1. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
2. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
3. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases
4. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
5. Effect of inhaled formoterol and budesonide on exacerbations of asthma
6. Combined salmeterol 50 μg and fluticasone propionate 250 μg in the Diskus device for the treatment of asthma
7. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial
8. Salmeterol/fluticasone propionate (50/500 μg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma
9. Inhaled salmeterol and fluticasone: A study comparing monotherapy and combination therapy in asthma
10. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: A multicenter, randomized, double-blind trial
11. Reference spirometric values using techniques and equipment that meet ATS recommendations
12. Measuring quality of life in asthma
13. Determining a minimal important change in a disease-specific quality of life questionnaire
14. Lung function testing: Selection of reference values and interpretative strategies
15. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
16. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
17. The complementary role of glucocorticoids and long-acting β-adrenergic agonists
18. 2-adrenergic receptor transcription in human lung
19. Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation
20. 2-adrenergic receptor function in human nasal mucosa
21. 2-agonists and corticosteroids on tumor necrosis factor-α-induced interleukin-8 release from cultured human airway smooth muscle cells
22. Asthma guidelines: An assessment of physician understanding and practice
23. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial
24. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
25. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial